Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes... Show more
CDXS is expected to report earnings to fall 24.38% to -9 cents per share on October 29
Q3'26
Est.
$-0.10
Q2'26
Beat
by $0.01
Q1'26
Beat
by $0.06
Q4'25
Beat
by $0.15
Q3'25
Missed
by $0.07
The last earnings report on August 11 showed earnings per share of -12 cents, beating the estimate of -14 cents. With 845.69K shares outstanding, the current market capitalization sits at 182.87M.